You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 140 No. 4, April 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (30)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Disorders
 •Dermatologic Disorders, Other
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Dermatologic and Immunologic Findings in the Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked Syndrome

David S. Nieves, MD; Richard P. Phipps, PhD; Stephen J. Pollock, BS; Hans D. Ochs, MD; Qili Zhu, PhD; Glynis A. Scott, MD; Charlotte K. Ryan, MD; Ichiro Kobayashi, MD, PhD; Thomas M. Rossi, MD; Lowell A. Goldsmith, MD

Arch Dermatol. 2004;140:466-472.

Background  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is a rare genodermatosis associated with dermatitis, enteropathy, type 1 diabetes, thyroiditis, hemolytic anemia, and thrombocytopenia. IPEX results from mutations of FOXP3, a gene located on the X chromosome that encodes a DNA-binding protein required for development of regulatory T cells. If untreated, affected males die early in life from malabsorption and other complications. To our knowledge, this syndrome has never been described in the dermatology literature.

Observations  We studied an 11-year-old boy with IPEX. Mutation analysis revealed a G->A transition (1150G>A) in exon 11, resulting in a putative substitution of Ala->Thr at residue 384, within the DNA-binding site. Histopathologic examination of an active skin lesion revealed psoriasiform dermatitis. The lesions improved with clobetasol ointment. The patient also displayed alopecia universalis, which had been present since age 18 months, accompanied by longitudinal ridging of the nails. Lymphocyte challenge tests revealed a profound inability to synthesize interferon {gamma} (INF-{gamma}) and dysregulated production of other cytokines.

Conclusions  IPEX is an often fatal genodermatosis associated with multiple autoimmune disorders. Cutaneous findings may include dermatitis, bullae, urticaria, alopecia universalis, and trachyonychia. Recognition of this life-threatening disorder is crucial for optimal treatment and genetic counseling.


From the Departments of Dermatology (Drs Nieves and Scott), Microbiology and Immunology (Dr Phipps and Mr Pollock); Pathology (Dr Ryan), and Pediatrics (Dr Rossi), University of Rochester, Rochester, NY; Departments of Pediatrics, University of Washington, Seattle (Drs Ochs and Zhu), and Hokkaido University School of Medicine, Sapporo, Japan (Dr Kobayashi); and Dermatology, University of North Carolina–Chapel Hill, Chapel Hill (Dr Goldsmith). The authors have no relevant financial interest in this article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Foxp3 Regulates Megakaryopoiesis and Platelet Function
Bernard et al.
Arterioscler. Thromb. Vasc. Bio. 2009;29:1874-1882.
ABSTRACT | FULL TEXT  

FOXP3 Forkhead Domain Mutation and Regulatory T Cells in the IPEX Syndrome
d'Hennezel et al.
NEJM 2009;361:1710-1713.
FULL TEXT  

A Mystery Diagnosis: Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Recessive
Gischel et al.
Lab Med 2009;40:303-306.
ABSTRACT | FULL TEXT  

Regulatory T Cells Are Reduced During Anti-CD25 Antibody Treatment of Multiple Sclerosis
Oh et al.
Arch Neurol 2009;66:471-479.
ABSTRACT | FULL TEXT  

Neonatal Diabetes Mellitus
Aguilar-Bryan and Bryan
Endocr. Rev. 2008;29:265-291.
ABSTRACT | FULL TEXT  

Functional Study of CD4+CD25+ Regulatory T Cells in Health and Autoimmune Hepatitis
Longhi et al.
J. Immunol. 2006;176:4484-4491.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.